Wrist Joint Injection

Evidence at a Glance

The wrist region carries more distinct injection codes than any other joint in this series, and each target has its own code, modifier rules, and supported diagnoses. The wrist joint itself is an intermediate joint (20605/20606), but a carpal tunnel injection has its own code (20526), a ganglion cyst aspiration/injection is 20612, a de Quervain's / tendon-sheath injection is 20550, and the thumb basal joint codes as a small joint. Coding the wrong structure into the joint code - or mis-applying modifier 50 - is the defining error. Hyaluronic acid is not covered for the wrist.

Domain	Summary
Medicare NCD	No national coverage determination specific to wrist injection. Corticosteroid/anesthetic injection is broadly covered when medically necessary.
Medicare LCD / Article	MAC articles specifically address tendon-sheath, ligament, ganglion, and carpal-tunnel injections (for example A52863, A57079), including supported diagnoses and modifier rules.
Commercial Coverage	Covered as medically necessary for qualifying wrist pathology, with payer diagnosis-to-procedure lists (for example UnitedHealthcare) that require a supporting diagnosis for each code.
Evidence Level	Moderate short-term benefit for carpal tunnel syndrome, de Quervain's tenosynovitis, ganglion, and wrist osteoarthritis; guidance improves accuracy for small targets.
Image Guidance	Optional. Ultrasound is bundled into 20606 for the wrist joint; for the dedicated codes (20526, 20612, 20550), ultrasound guidance is reported separately with 76942 when a permanent image is retained.
Prior Authorization	Generally not required for corticosteroid injection. Verify plan-specific rules; wrist hyaluronic acid is denied regardless.
Conservative Therapy	Document splinting, activity modification, therapy, and analgesics/NSAIDs before injection (especially for carpal tunnel and de Quervain's).
Diagnostic Block	Not typically required. An anesthetic component can localize the pain source within the same encounter.
Key Documentation	The specific target (wrist joint / carpal tunnel / ganglion / tendon sheath / thumb basal joint), laterality, guidance modality, injectate and units, and pre-/post pain scores.
Approval Considerations	Target-correct code, a supported laterality-specific diagnosis, correct modifier-50 handling per code, and documented conservative care.

Procedure Overview

Wrist-region injections deliver corticosteroid and/or anesthetic to one of several structures: the wrist (radiocarpal) joint for osteoarthritis or inflammatory arthropathy, the carpal tunnel for median-nerve compression, a ganglion cyst for aspiration and injection, the first dorsal compartment for de Quervain's tenosynovitis, or the thumb basal joint for basilar thumb osteoarthritis. Most targets are accessible by landmark technique, with ultrasound used selectively to confirm placement in small or crowded spaces.

Operationally, the wrist is the clearest example in this series of a body region that maps to a family of distinct procedure codes rather than a single code. The carpal tunnel, the ganglion, and the tendon sheath each have their own code, supported-diagnosis list, and modifier rules. The controlling discipline is documenting the exact structure so the correct dedicated code is selected instead of defaulting to the intermediate-joint code.

Relevant Anatomy (High-Level)

The relevant structures are the radiocarpal and intercarpal joints, the carpal tunnel (through which the median nerve passes beneath the transverse carpal ligament), the first dorsal compartment tendons (abductor pollicis longus and extensor pollicis brevis, involved in de Quervain's tenosynovitis), ganglion cysts (most commonly dorsal), and the thumb basal (first carpometacarpal) joint. Each is a distinct anatomic target with a distinct code. The key coding fact is that the carpal tunnel, tendon sheaths, and ganglia are not "the wrist joint," and their injections are not reported with the joint code.

Clinical Indications

Carpal tunnel syndrome with median-nerve symptoms, for therapeutic carpal-tunnel injection.
de Quervain's tenosynovitis of the first dorsal compartment.
Symptomatic ganglion cyst for aspiration and/or injection.
Wrist osteoarthritis or inflammatory arthropathy with intra-articular pain, or symptomatic effusion requiring aspiration.
Thumb basal (first carpometacarpal) joint osteoarthritis.
Symptoms persisting despite documented conservative care.

Patient Selection

Selection depends on localizing the pain generator so the correct target is injected and coded:

Examination and, where indicated, electrodiagnostic or imaging findings localizing the pathology (for example nerve conduction studies for carpal tunnel syndrome).
A documented trial of, or contraindication to, conservative management including splinting and therapy.
Functional impairment the injection is intended to improve (grip, pinch, nocturnal symptoms).
Realistic expectations, particularly that carpal-tunnel injection is often a temporizing or diagnostic measure rather than a definitive cure.
Aspiration considered where a symptomatic ganglion or joint effusion is present.

Contraindications

Absolute	Relative
Overlying infection; suspected septic joint or sheath.	Therapeutic anticoagulation or coagulopathy (individualized).
Known allergy to the planned injectate.	Poorly controlled diabetes (corticosteroid glycemic effect).
Patient refusal or inability to cooperate.	Superficial subcutaneous target (skin atrophy, depigmentation risk).

Progressive or severe carpal tunnel syndrome that warrants surgical evaluation.

Medical Necessity

Medical necessity is established by documenting the pain generator, the failure of conservative care, and the therapeutic goal. Payers expect:

The specific target and a supported diagnosis consistent with it (for example carpal tunnel syndrome for a carpal-tunnel injection).
Laterality of the affected wrist.
A documented conservative-care trial and outcome, or a contraindication.
The functional deficit treated and the therapeutic goal.
The guidance modality and rationale where guidance is used.

Medicare Coverage Guidance

No National Coverage Determination is specific to wrist injection, but MACs publish articles addressing tendon-sheath, ligament, ganglion, and carpal-/tarsal-tunnel injections. Key principles:

Dedicated codes. Carpal tunnel is 20526; ganglion is 20612; tendon sheath (de Quervain's) is 20550; tendon origin/insertion is 20551. The wrist joint is 20605/20606.
Supported diagnoses. Each code has a supported-diagnosis list (for example G56.0- carpal tunnel codes for 20526); codes outside the list are denied.
Modifier 50. Do not report modifier 50 with 20612 (or 20551); modifier 50 may be reported, when appropriate, with 20550 and 20526. Bilateral services are otherwise reported on separate lines with RT and LT.
Single unit per site. Multiple injections at the same site on the same day are one injection, reported as one unit.
Combined services. A joint injection reported with a tendon injection in the same encounter requires documented medical necessity for the separate procedure and a distinct-service modifier.
Image guidance. Ultrasound is bundled into 20606 for the joint; for the dedicated codes it is reported separately with 76942 (retained image required).

Commercial Payer Comparison

Payer / Program	Typical Posture on Wrist-Region Injection
eviCore / Carelon / Cohere / Evolent	Corticosteroid joint, tendon, ganglion, and tunnel injections generally not managed by interventional-pain UM programs; verify any delegation.
Cigna	Covered for qualifying wrist pathology refractory to conservative care; viscosupplementation restricted to the knee.
Aetna	Considers corticosteroid wrist-region injection medically necessary for documented pathology; certain injectates for tendinopathy may be considered experimental.
UnitedHealthcare	Maintains a procedure-to-diagnosis policy for tendon-sheath, ligament, ganglion, and carpal-tunnel injections; reimburses only when a supporting diagnosis is on the claim.
Humana	Medicare Advantage aligns with CMS/MAC principles; commercial follows medical-necessity criteria with frequency edits.
Blue Cross Blue Shield plans	Plan-specific policies; corticosteroid injection covered for qualifying pathology; wrist viscosupplementation non-covered. Verify the local licensee policy.
Diagnosis-to-Procedure Lists Several payers, including UnitedHea and will not reimburse a code unles diagnosis-to-code matching a hard r	Are Enforced Here lthcare, maintain explicit procedure-to-diagnosis policies for wrist-region injections s an accurate, supporting diagnosis appears on the claim. This makes equirement rather than a best practice for the wrist.

Documentation Requirements

Specific target (wrist joint / carpal tunnel / ganglion / tendon sheath / thumb basal joint).
Laterality (right / left) documented.
Supported diagnosis consistent with the target.
Conservative therapy history and outcome.
Guidance modality (landmark / ultrasound).
For dedicated codes with ultrasound: retained image for 76942.
Injectate name, concentration, and units.
Pre-injection numeric pain score.
Post-injection pain score and immediate percent relief.
Functional impairment and therapeutic goal.
Correct dedicated code and modifier-50 handling.
Signed and dated procedure note.

Imaging Requirements

Diagnostic evaluation may include radiographs (wrist or thumb osteoarthritis), ultrasound (tenosynovitis, ganglion characterization), and, for carpal tunnel syndrome, nerve conduction studies and electromyography. Procedural guidance is optional and target-dependent. For the wrist joint, ultrasound guidance is bundled into 20606. For the dedicated codes (20526 carpal tunnel, 20612 ganglion, 20550 tendon sheath), ultrasound guidance is reported separately with 76942 when a permanent image is retained. Ultrasound is particularly valuable for small or crowded targets and for confirming needle position relative to the median nerve.

Prior Authorization Workflow

Benefit verification. Confirm coverage for the specific injection and the payer's diagnosis-to-procedure requirements; confirm wrist hyaluronic acid is non-covered before offering it.
Target identification. Determine and document the specific structure before the encounter where possible.
Diagnosis validation. Confirm a supported, laterality-specific diagnosis for the chosen code (for example G56.0- for carpal tunnel).
Conservative-care confirmation. Verify the documented trial satisfies the payer's expectation.
Guidance decision. Map guidance to reporting (bundled 20606 for the joint; separate 76942 for dedicated codes).
Procedure and coding. Select the correct dedicated code; apply modifier 50 only where permitted (20550, 20526), and RT/LT otherwise; one unit per site.
Post-service integrity. Ensure target, laterality, guidance, and pre-/post pain scores are recorded.

Common Prior Authorization & Claim Denials

Denial Reason	Root Cause / Prevention
Dedicated target coded as wrist joint	Carpal tunnel, ganglion, or tendon sheath billed as 20605. Use the dedicated code (20526 / 20612 / 20550).
Diagnosis not supported for the code	Code billed without a matching supported diagnosis. Pair each code with its supported diagnosis (for example G56.0- for 20526).
Modifier 50 mis-applied	Modifier 50 reported with 20612 (or 20551). Do not use modifier 50 on these; use RT/LT. Modifier 50 may be used with 20550/20526.
Guidance mis-reported	76942 added to a wrist-joint injection (bundled in 20606), or omitted for a dedicated code where used. Map guidance to the target.
Combined services unbundled without support	Joint plus tendon injection billed without documented separate necessity or a distinct-service modifier. Document and modify appropriately.
Unspecified laterality	Non-laterality diagnosis or missing RT/LT. Code laterality; note carpal tunnel has a bilateral diagnosis code (G56.03).
Wrist hyaluronic acid billed	Viscosupplementation is knee-only. Do not bill wrist HA; drug and injection deny.
Multiple units for one site	More than one unit for the same site/encounter. Report a single unit per site.

Appeal Strategies

Submit the procedure note documenting the specific target, laterality, guidance modality, injectate and units, and pre-/post pain scores.
For target-coding denials, confirm the correct dedicated code and resubmit if the joint code was used in error.
For diagnosis denials, correct to a supported, laterality-specific code for the code billed.
For modifier denials, correct the modifier-50 handling per the code's rules.
For guidance denials, supply the retained ultrasound image (for 76942) and the rationale.
Do not appeal wrist hyaluronic-acid denials on medical-necessity grounds; the non-coverage is categorical.

Coding & Billing Overview

Applicable CPT® Codes by Target

CPT®	Descriptor / Target	Application
20605 / 20606	Intermediate joint or bursa (without / with ultrasound)	Wrist (radiocarpal) joint.
20526	Injection, therapeutic; carpal tunnel	Carpal tunnel syndrome.
20612	Aspiration and/or injection of ganglion cyst(s), any location	Wrist ganglion cyst.
20550	Injection(s); single tendon sheath, ligament, aponeurosis	de Quervain's / first dorsal compartment tenosynovitis.
20600 / 20604	Small joint or bursa (without / with ultrasound)	Thumb basal (first carpometacarpal) joint (verify per payer).

HCPCS (Injectate)

Corticosteroid is reported with the appropriate J-code (for example J1030 methylprednisolone acetate 40 mg, or J3301 triamcinolone acetonide per 10 mg) on the same claim. Local anesthetics are frequently not separately payable. Hyaluronic acid supply codes apply to the knee only and should not be reported for the wrist.

Common ICD-10-CM Diagnosis Codes

Code	Description	Paired Code / Target
G56.01 / G56.02 / G56.03	Carpal tunnel syndrome, right / left / bilateral	20526 (carpal tunnel).
M65.4	Radial styloid tenosynovitis (de Quervain)	20550 (tendon sheath).
M67.431 / M67.432	Ganglion, right / left wrist	20612 (ganglion).
M19.031 / M19.032	Primary osteoarthritis, right / left wrist	20605/20606 (joint).
M18.11 / M18.12	Primary OA, first carpometacarpal joint, right / left	20600/20604 (thumb basal joint).
M25.531 / M25.532	Pain in right / left wrist	When specific diagnosis not established.

Modifiers, POS & ASC

Element	Guidance
Modifier 50	May be used with 20550 and 20526 for bilateral; not with 20612 or 20551. Otherwise report RT/LT on separate lines.
Modifier RT / LT	Identify the wrist; required where modifier 50 is not used.
Modifier 59 / X{EPSU}	For a genuinely distinct additional structure (for example joint plus tendon sheath), with documentation.
Modifier 25	For a significant, separately identifiable E/M on the same day.
Place of Service	POS 11 (office) typical; POS 22 or 24 where applicable.
ASC considerations	Predominantly office-based; ASC use is uncommon.

Clinical Documentation Checklist

Specific target documented.
Laterality (RT / LT).
Supported diagnosis matched to code.
Conservative therapy trial and outcome.

Guidance modality and (for dedicated codes) image retained.
Injectate name, concentration, units.
Pre-injection numeric pain score.
Post-injection pain score and percent relief.
Correct dedicated code selected.
Modifier-50 handling correct for the code.
No wrist hyaluronic acid billed.
Functional goal documented.

Procedure Comparison

Target	CPT®	Diagnosis	Modifier 50?
Wrist joint	20605 / 20606	M19.03-	Per payer (RT/LT)
Carpal tunnel	20526	G56.0-	May be used
Ganglion cyst	20612	M67.43-	Not used (RT/LT)
de Quervain's / tendon sheath	20550	M65.4	May be used
Thumb basal joint	20600 / 20604	M18.1-	Per payer (RT/LT)

GoHealthcare Clinical Insights

Treat the wrist as a code family, not a code. The defining wrist error is defaulting a carpal-tunnel, ganglion, or tendon-sheath injection to the joint code. A note template that forces target selection among the wrist joint, carpal tunnel, ganglion, tendon sheath, and thumb basal joint routes each to its dedicated code. Pair the diagnosis to the code at entry. Because payers enforce procedure-to-diagnosis lists here, the supported diagnosis (for example a carpal-tunnel code with 20526) should be confirmed before the claim drops, not corrected after denial. Build a modifier-50 rule per code. Modifier 50 is permitted for 20550 and 20526 but not for 20612 or 20551. Encoding this rule prevents a subtle but recurring bilateral-billing denial.

GoHealthcare Leadership Perspective

The wrist is the densest coding environment in this series: one body region, five or more distinct codes, each with its own supported diagnoses and modifier rules. The organizational risk is a documentation and coding habit that collapses this complexity into a single joint code, generating both under-coding and mis-coding. The leadership priorities are a note template that forces target selection, a coding rule set that routes each target to its dedicated code with the correct modifier-50 handling and guidance reporting, and a diagnosis-to-code check that satisfies payer procedure-to-diagnosis policies. These controls turn a dense, error-prone region into a precise, defensible one.

GoHealthcare Prior Authorization Insight

The authorization insight for the wrist is that the exposure is coding precision and diagnosis pairing, not authorization friction. Corticosteroid wrist-region injections rarely require prior authorization, but they deny for target mis-coding, unsupported diagnoses, and modifier-50 errors that no authorization step would catch. Our quality-assurance approach verifies target-to-code alignment, diagnosis-to-code support against payer procedure-to-diagnosis lists, and code-specific modifier-50 handling before the claim drops, and excludes wrist hyaluronic acid categorically. This front-loads the precision the payer will otherwise enforce on review.

GoHealthcare Case Study

The following case is a composite created for education. It does not depict any actual patient or organization.

Clinical Scenario

A patient with bilateral carpal tunnel syndrome, refractory to nocturnal splinting, underwent same-session carpal-tunnel injections of both wrists. The practice billed 20605 for each wrist with a generic wrist-pain diagnosis and no laterality handling.

Documentation & Coding Challenges

The claim denied. Carpal-tunnel injection has a dedicated code (20526), not the wrist-joint code 20605; the diagnosis should have been carpal tunnel syndrome with laterality (and the bilateral code G56.03 was available); and the bilateral service should have been reported with modifier 50 (permitted for 20526) or on separate RT/LT lines rather than as two unmarked joint injections.

Payer & Prior Authorization Barriers

No prior authorization was required, so no checkpoint validated the target-to-code alignment or the diagnosis pairing against the payer's procedure-to-diagnosis policy before submission.

Resolution Strategy

The practice recoded to 20526 with carpal tunnel syndrome diagnoses and correct bilateral handling, and resubmitted. Prospectively, it added a target-selection field routing carpal tunnel, ganglion, and tendon-sheath injections to their dedicated codes, and a diagnosis-to-code check tied to payer procedure-to-diagnosis lists.

Outcome & Lessons Learned

The corrected claim was paid, and wrist-region denials fell in the following quarter. The lesson: the wrist demands a code-family approach - correct dedicated code, supported diagnosis, and code-specific modifier handling - all enforced at the front end.

GoHealthcare Best Practices

Require target selection (wrist joint / carpal tunnel / ganglion / tendon sheath / thumb basal joint) in the note template.
Route each target to its dedicated code (20526 / 20612 / 20550 / 20600 / 20605).
Pair each code with a supported, laterality-specific diagnosis before the claim drops.
Encode code-specific modifier-50 rules (permitted for 20550/20526; not for 20612/20551).
Apply the correct guidance reporting (bundled 20606; separate 76942 for dedicated codes).
Block wrist hyaluronic acid at the claim-edit level.

Common Mistakes

Coding a carpal-tunnel, ganglion, or tendon-sheath injection as a wrist-joint injection.
Reporting a code without a supported, matching diagnosis.
Applying modifier 50 to 20612 (or 20551), where it is not permitted.
Adding 76942 to a wrist-joint injection (guidance is bundled in 20606).
Omitting separately reportable ultrasound guidance for a dedicated code.
Using a generic wrist-pain diagnosis for a specific target.
Billing wrist hyaluronic acid, which is non-covered.
Omitting laterality or pre-/post pain scores.

Pearls and Pitfalls

Pearls	Pitfalls
Route each target to its dedicated code.	Defaulting every wrist injection to 20605.
Pair the diagnosis to the code at entry.	Reporting a code with an unsupported diagnosis.
Encode modifier-50 rules per code.	Applying modifier 50 to 20612 or 20551.
Apply guidance reporting by target.	Adding 76942 to a bundled joint code.
Use the bilateral carpal-tunnel diagnosis when apt.	Missing G56.03 for bilateral carpal tunnel syndrome.

Frequently Asked Questions

What code is used for a wrist (radiocarpal) joint injection?

20605 (without ultrasound) or 20606 (with ultrasound). The wrist is an intermediate joint.

What code is used for a carpal-tunnel injection?

20526 (Injection, therapeutic; carpal tunnel). It is a dedicated code, not the wrist-joint code.

What code is used for a ganglion cyst aspiration/injection?

20612 (Aspiration and/or injection of ganglion cyst(s), any location).

What code is used for a de Quervain's injection?

20550 (injection of a single tendon sheath), for the first dorsal compartment tenosynovitis.

How is a thumb basal-joint injection coded?

As a small joint (20600 without ultrasound, 20604 with ultrasound). Verify the classification with the payer.

Which wrist codes can take modifier 50?

Modifier 50 may be reported with 20550 and 20526 for bilateral service, but not with 20612 or 20551. Otherwise report RT and LT on separate lines.

What diagnosis supports a carpal-tunnel injection?

Carpal tunnel syndrome codes: G56.01 (right), G56.02 (left), G56.03 (bilateral), or G56.00 (unspecified). Payer policy commonly requires one of these for 20526.

What is the de Quervain's diagnosis code?

M65.4 (radial styloid tenosynovitis, de Quervain).

What is the wrist ganglion diagnosis?

M67.431 (right wrist) or M67.432 (left wrist), matched to 20612.

How do I report ultrasound guidance at the wrist?

For the wrist joint, ultrasound is bundled into 20606. For the dedicated codes (20526, 20612, 20550), report ultrasound guidance separately with 76942 when a permanent image is retained.

Is hyaluronic acid covered for the wrist?

No. Hyaluronic acid is covered for the knee only; wrist viscosupplementation is non-covered.

How many units per site?

One. Multiple injections at the same site on the same day are one injection, reported as one unit.

Can I bill a joint injection and a tendon injection together?

Only with documented medical necessity for the separate procedure and an appropriate distinct-service modifier; otherwise the second service denies.

Does wrist injection require prior authorization?

Corticosteroid injection usually does not. Verify plan rules; wrist hyaluronic acid is non-covered regardless.

Is conservative care required first?

Frequently, especially for carpal tunnel (splinting) and de Quervain's. Document the trial and outcome.

Is carpal-tunnel injection curative?

Often it is temporizing or diagnostic rather than definitive; document realistic expectations and the plan, including surgical referral where appropriate.

What place of service applies?

POS 11 (office) is typical; POS 22 or 24 where applicable.

Why did my wrist claim deny?

Common causes are coding a dedicated target as the joint, an unsupported diagnosis, or a modifier-50 error. Correct and resubmit.

Does carpal tunnel syndrome have a bilateral diagnosis code?

Yes, G56.03. Use it when bilateral carpal tunnel syndrome is documented.

What single control most reduces wrist-region denials?

A target-selection field that routes each structure to its dedicated code, paired with a diagnosis-to-code check.

Can I bill an E/M on the same day?

Only for a significant, separately identifiable evaluation beyond the injection work, with modifier 25.

Is electrodiagnostic testing needed before carpal-tunnel injection?

Nerve conduction studies/EMG support the diagnosis and are commonly documented, though requirements vary by payer and clinical scenario.

Key Takeaways

The wrist region maps to several dedicated codes: joint (20605/20606), carpal tunnel (20526), ganglion (20612), tendon sheath (20550), thumb basal joint (20600/20604).
Do not default a dedicated target to the wrist-joint code.
Modifier 50 may be used with 20550/20526 but not with 20612/20551; otherwise use RT/LT.
Pair each code with a supported, laterality-specific diagnosis; payers enforce procedure-to-diagnosis lists.
Ultrasound is bundled into 20606 for the joint but reported separately (76942) for the dedicated codes.
Carpal tunnel syndrome has a bilateral diagnosis code (G56.03).
Hyaluronic acid is not covered for the wrist.

Future Outlook

Ultrasound will continue to expand for wrist-region injections, improving accuracy for small targets and confirming needle position relative to the median nerve, and reinforcing correct, target-specific guidance reporting. Payer procedure-to-diagnosis enforcement is likely to tighten, making diagnosis-to-code pairing increasingly decisive. Corticosteroid wrist-region injection will remain a covered, commonly performed service, while wrist viscosupplementation remains non-covered. Practices that adopt a code-family approach with dedicated-code routing and diagnosis pairing now will adapt smoothly as edits tighten.

References

American Medical Association. CPT® 2026 Professional Edition (20526, 20550, 20551, 20600, 20604, 20605, 20606, 20612). https://www.ama-assn.org/practice-management/cpt Centers for Medicare & Medicaid Services. Billing and Coding: Pain Management - injection of tendon sheaths, ligaments, ganglion cysts, carpal and tarsal tunnels (A52863) - modifier and unit rules. https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=52863 Centers for Medicare & Medicaid Services. Billing and Coding: Injections - Tendon, Ligament, Ganglion Cyst, Tunnel Syndromes and Morton's Neuroma (A57079) - supported diagnoses (G56.0- for 20526). https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleId=57079 UnitedHealthcare. Injections into Tendon Sheath, Ligament, Ganglion Cyst, Carpal/Tarsal Tunnel - procedure-to-diagnosis policy. https:// www.uhcprovider.com/content/dam/provider/docs/public/policies/medicaid-comm-plan-reimbursement/UHCCP-Injections-Tendon-Sheath-L igament-Ganglion-Cyst-Carpal-Tarsal-Tunnel-Policy.pdf ICD-10-CM 2026, G56.0- (Carpal tunnel syndrome), M65.4 (de Quervain), M67.43- (Ganglion of wrist), M19.03- (Primary OA of wrist), M18.1- (First CMC joint OA). https://www.icd10data.com/ICD10CM/Codes American Society for Surgery of the Hand (ASSH). https://www.assh.org American Academy of Orthopaedic Surgeons (AAOS). https://www.aaos.org

Reading Recommendations

AMA CPT® guidance distinguishing joint, tendon-sheath, ganglion, and tunnel injection codes.
Your MAC's tendon-sheath/ganglion/carpal-tunnel injection article and supported-diagnosis lists.
Payer procedure-to-diagnosis policies for wrist-region injections.
ASSH and AAOS guidance on carpal tunnel syndrome and de Quervain's tenosynovitis.

Recommended Downloads

Wrist Injection Structured Note Template (with required target field).
Target-to-Code Quick-Reference (joint / carpal tunnel / ganglion / tendon sheath / thumb basal joint).
Modifier-50 Rules Cheat Sheet (by code).
Diagnosis-to-Code Pairing Worksheet (procedure-to-diagnosis compliance).

Visual Recommendations

High-level illustration of wrist-region injection targets (joint, carpal tunnel, ganglion, first dorsal compartment, thumb basal joint).
Target-to-code decision tree with dedicated codes.
Modifier-50 decision matrix by code.
Diagnosis-to-code pairing matrix.
Guidance-reporting decision flow (bundled vs separate).
Documentation checklist infographic for point-of-care use.

Educational Disclaimer

This document is intended for educational and operational reference purposes only. It does not replace physician clinical judgment, payer policy review, legal advice, or official CMS guidance, and it is not a procedural or physician training manual. Coverage policies, coding guidance, frequency limitations, and reimbursement requirements change frequently and vary by payer, plan, and jurisdiction; all codes and coverage criteria must be independently verified against the applicable payer policy and current regulatory sources before submission. CPT® is a registered trademark of the American Medical Association. GoHealthcare Practice Solutions assumes no liability for actions taken in reliance on this educational material.

This webpage does not replace physician judgment, official payer policy, legal advice, or current coding guidance. CPT® is a registered trademark of the American Medical Association.